Xilio Therapeutics, Inc. (XLO) Capital expenditures 2020–2025
Xilio Therapeutics, Inc. (XLO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$518,000FY2025 · since FY2020: $2.2M → $518,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $518,000 | +1338.9% |
| FY2024 | $36,000 | -92.6% |
| FY2023 | $486,000 | -74.0% |
| FY2022 | $1.9M | +69.7% |
| FY2021 | $1.1M | -49.7% |
| FY2020 | $2.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice